C5 and complement 3 glomerulopathy: C5 blockade protected C3KI mice from disease, and through long-term studies of C5 genetic deletion, we have shown that while increased C3 turnover continues through dysregulation of the alternative pathway, this does not evolve into a C3 glomerulopathy.